Sodium Nitrophenolate Suppresses Grapevine Fungal Growth
The treatment reduces lesion length in lab tests, marking a potential shift in managing hard-to-treat vine trunk diseases.
Updated on Oct. 21, 2026 in Botany
Live Poll
Should farmers prioritize testing new scientific treatments for common crop diseases in their local operations?
Researchers have demonstrated that the sodium nitrophenolate-based treatment Atonik can inhibit fungal pathogens in grapevines. In an in vitro study, the compound reduced lesion lengths and triggered gene expression responses associated with plant defense.
Why it matters
Grapevine trunk diseases currently lack effective curative control, creating a significant constraint for global agricultural production. This study offers a potential new mechanism for managing these fungal pathogens by boosting the plant's inherent defense systems.
The study tested Atonik's efficacy against 10 fungal pathogens, identifying 43 genes associated with the treatment and 168 genes linked to infection. Treated grapevines showed higher abundance of VvSOD transcripts, which are key proteins involved in the plant's oxidative stress response.
The players
Atonik
A commercially available plant growth stimulant and biostimulant formulated with sodium nitrophenolate.
The details
Researchers applied Atonik to ten fungal pathogens, using absolute quantitative polymerase chain reaction (qPCR) — a method to measure specific DNA sequences — to gauge the plant's defense response. RNA-sequencing, which captures the total set of gene transcripts active in a cell, revealed that the treatment modulates the vine's genetic response to fungal encroachment. The observed reduction in lesion length suggests the compound limits mycelial growth, the vegetative branching part of fungi, though the specific pathway for this inhibition remains in the research stage.
Timeline
October 21, 2026: Study published on bioRxiv.
The Tech Race
This study advances the management of grapevine trunk diseases by identifying a specific chemical mechanism to mitigate lesion growth, addressing a persistent void in curative agricultural tools. It follows a long-standing pattern of researchers testing existing biostimulants to find viable alternatives to ineffective chemical fungicides.
Vineyard operators and agricultural producers currently have no commercially validated curative path using this specific compound, as this study remains in the research stage. Future field trials will be required to determine if these findings can scale to protect commercial crop yields.
The takeaway
This study highlights how biostimulants might be repurposed to fortify plant immune responses against previously untreatable trunk diseases. Watch for upcoming field trial results to see if these in vitro findings translate into real-world reductions in vine mortality.
Further reading
Explore more developments in agricultural plant physiology in our Botany section.
Source note: This article includes information reported by Biorxiv.
Live Poll
Should farmers prioritize testing new scientific treatments for common crop diseases in their local operations?
